Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$777,206
-$125,874 QoQ
Shares Held
32,276
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,468
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Towne Trust Company, N.A holds $24,022,988 across 11 Drug Manufacturers - General names. PFE ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
44,360 | $11,266,108 | |
| 2 | AMGN |
Amgen Inc
|
19,650 | $7,115,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,771 | $3,183,073 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,251 | $936,382 | |
| 5 | PFE |
Pfizer Inc
This page
|
32,276 | $777,206 | |
| 6 | ABBV |
AbbVie Inc.
|
1,193 | $300,206 | |
| 7 | LLY |
ELI LILLY & Co
|
224 | $268,672 | |
| 8 | AZN |
Astrazeneca PLC
|
612 | $116,047 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $777,206 | 32,276 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $903,080 | 32,161 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,083,796 | 43,526 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,515,116 | 59,463 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,514,102 | 62,463 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,627,410 | 64,223 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,726,386 | 65,073 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,911,573 | 66,053 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,827,177 | 65,303 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,846,845 | 66,553 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,589,265 | 55,202 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,848,464 | 55,727 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,979,875 | 53,977 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,186,553 | 53,592 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,518,548 | 49,152 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,139,950 | 48,902 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,725,940 | 51,992 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,533,571 | 48,939 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,905,790 | 49,209 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,041,899 | 47,475 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,939,438 | 49,526 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,783,457 | 49,226 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,749,431 | 47,526 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,753,780 | 47,787 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,563,584 | 47,816 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,585,256 | 48,568 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||